用肠道病毒3C蛋白酶进行基因治疗:针对各种固体瘤的有希望的策略
Xiaotong Yang1,2, Wei Li1, Shaokang Yang1
1National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing, China.
Nature communications
|May 9, 2025
概括
新的脂质纳米颗粒 (LNP) 传递编码病毒3C蛋白酶的mRNA,直接诱导癌细胞亡,提供一种新的基因治疗方法. 这种方法在抑制各种固体瘤方面显著有前途,包括质母细胞瘤和乳腺癌.
科学领域:
- 在瘤学瘤学.
- 基因治疗 基因治疗
- 分子生物学分子生物学
背景情况:
- 目前的癌症基因疗法主要利用抗瘤免疫力.
- 对于具有直接抗瘤作用的替代mRNA货物,以扩大治疗选择,有着至关重要的需求.
研究的目的:
- 研究载有病毒3C蛋白酶编码的信使RNA (mRNA) 的脂质纳米粒子 (LNP) 作为直接抗瘤治疗的潜力.
- 评估这种方法在各种固体瘤模型中的有效性.
主要方法:
- 脂质纳米颗粒 (LNP) 被设计为携带编码病毒3C蛋白酶的mRNA.
- 3C-LNP在不同的固体瘤模型中通过内注射,皮下注射和静脉注射.
- 评估了瘤生长,存活率和血管生成.
- 质谱和分离部位预测试验被用于识别蛋白酶标.
主要成果:
- 内注射3C-LNP显著抑制瘤生长和延长质母细胞瘤模型中的存活时间.
- 在乳腺癌模型中,皮下注射减少了瘤体积,并抑制了血管生成.
- 在肝细胞癌模型中,静脉注射显示出瘤生长抑制,血管新生减少和延长存活时间.
- 异质核核核糖核蛋白A1 (hnRNP A1) 被确定为由3C蛋白酶降解的主要标.
结论:
- 通过LNP传递的编码病毒3C蛋白酶的mRNA可以选择性地诱导瘤细胞亡并抑制瘤生长.
- 这种方法在各种固体瘤模型中展示了广泛的抗瘤活性.
- 病毒蛋白酶mRNA代表了下一代癌症基因治疗的有希望的候选人.
相关概念视频
00:59Gene Therapy
24.9K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
24.9K
01:27Tumor Immunotherapy
401
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
401